# A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

> **NCT03136237** · PHASE1 · COMPLETED · sponsor: **BioCryst Pharmaceuticals** · enrollment: 54 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** BCX7353
- **DRUG:** Digoxin
- **DRUG:** BCX7353 + digoxin
- **DRUG:** Rosuvastatin
- **DRUG:** rosuvastatin + BCX7353
- **DRUG:** Cyclosporine + BCX7353

## Key facts

- **NCT ID:** NCT03136237
- **Lead sponsor:** BioCryst Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2017-08-15
- **Final completion:** 2017-08-15
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136237, "A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03136237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*